Nosenzo John
Known title: CHIEF COMMERCIAL OFFICERCIK: 0001835973
Associated companies
Transaction History
| TELA | ▲ Buy | Grant | 3,135 | $0 | 6/1/2023 | View on chart |
| BVS | ▼ Sell | Open Market | 7 | $49 | 10/3/2022 | View on chart |
| BVS | ▼ Sell | Open Market | 95 | $639 | 7/1/2022 | View on chart |
| TELA | ▲ Buy | Grant | 3,135 | $0 | 6/1/2022 | View on chart |
| BVS | ▼ Sell | Open Market | 65,963 | $734K | 4/4/2022 | View on chart |
| BVS | ▲ Buy | Option Exercise | 106,485 | — | 4/1/2022 | View on chart |
| BVS | ▼ Sell | Open Market | 40 | $563 | 4/1/2022 | View on chart |
| BVS | ▼ Sell | Open Market | 534 | $6K | 2/14/2022 | View on chart |
| BVS | ▲ Buy | Option Exercise | 1,470 | — | 2/11/2022 | View on chart |
| BVS | ▼ Sell | Tax Withholding | 24,205 | $312K | 2/10/2022 | View on chart |
| BVS | ▲ Buy | Option Exercise | 66,139 | — | 2/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Craig-Hallum initiates coverage on TELA Bio with $2 target
Craig-Hallum has started tracking TELA Bio, assigning a price target of $2. This new analyst note aligns with the current average analyst target of $2.08. The stock is currently trading above its 52-week low of $0.50, with recent technical indicators showing momentum near the upper end of its recent range.
Craig-Hallum initiates coverage on TELA Bio with $2 target. Craig-Hallum has started tracking TELA Bio, assigning a price target of $2. This new analyst note aligns with the current average analyst target of $2.08. The stock is currently trading above its 52-week low of $0.50, with recent technical indicators showing momentum near the upper end of its recent range.